43 2.5: References

Unit 2-Work Cited

1. Monette, Anne, et al. “Chitosan Thermogels for Local T Lymphocyte Delivery for Cancer Immunotherapy.” Journal for ImmunoTherapy of Cancer, vol. 3, no. S2, 2015, doi:10.1186/2051-1426-3-s2-p36.
2. Yang, Yiping. “Cancer Immunotherapy: Harnessing the Immune System to Battle Cancer.” Journal of Clinical Investigation, vol. 125, no. 9, 2015, pp. 3335–3337., doi:10.1172/jci83871.
3. Naing, Aung, and Joud Hajjar. Immunotherapy. Springer, 2020.
4. Murphy, Kenneth, et al. Janeway’s Immunobiology. Garland, 2008.
5. Cohen, Ezra. “What Is Immunotherapy?” Cancerresearch.org. p.1, 2020. Web. 14 Dec. 2020.
6. Wolchok, Jedd. “Immunotherapy for Melanoma.” Cancerresearch.org. p.1, 2020. Web. 14 Dec. 2020.
7.  Schmidt, Charles. “The Benefits of Immunotherapy Combinations.” Nature p.1, 2017. Print.
8. Ventola, C. Lee. “Cancer Immunotherapy, Part 3: Challenges and Future Trends.” P & T: a peer-reviewed journal for formulary management. p. 514–518, 2017. Print.
9. Vestweber, Dietmar. “How Leukocytes Cross the Vascular Endothelium.” Nature reviews. Immunology .p.692,2015. Print.